There’s no denying it, change can be scary. So when the world’s hub of social media interactivity announces drastic changes that directly affect you and your brand’s marketing presence, you may ...

Is the FDA's snail-like response to the changing marketing landscape merely annoying, or is it worse than that? Heartbeat CEO Bill Drummy believes that the FDA's refusal to provide meaningful,...

"Eighteen months ago, 80 of my closest friends and I presented before the US Food and Drug Administration on how the agency should regulate the promotion of medical products via the internet and...

It's always fun to be accused of intellectual inconsistency in front of 500 people. Last week at the ePharma summit in NYC, I said that "social media in Pharma is a big fat red herring." By which I...

"Twitter, Facebook and YouTube, the social media triumvirate, if you will, aren't really social media at all without a real-time dialogue between brand and patient, says Bill Drummy, Heartbeat...

"Bill Drummy, one of the multitude of thought leaders to speak at the US Food and Drug Administration hearing on using the internet and social media to promote medical products, gives his take on the ...

The U.S. Food and Drug Administration will hold a two-day public hearing in November on how pharmaceutical companies use the web and social-media tools to market their products, the first step in a...